Introduction
Aqueous extracts of branches of Calliandra anomala (Kunth) Macbr. (Leguminosae) are used as an antimalarial and antifebrile agent in Mexico [1] . From this plant were reported fifteen complex triterpenoid saponins, called calliandra saponins (A-O) [2 -5] . Calliandra pulcherrima Benth. and Calliandra brevifolia Benth. are related native species found in Tropical America. These evergreen plants are non invasive, but widespread ornamental plants often cultivated in gardens and parks [6] . In Brazil, the aqueous extract of the branches of C. pulcherrima is used as a remedy for malaria and leishmaniasis [7] . From this plant we reported a complex triterpenoid saponin, pulcherrimasaponin (CP05), with adjuvant activity for immunization in the murine model of visceral leishmaniasis [8] . Studies on the constituents of leaves of Calliandra species, in particular C. brevifolia, have been conducted in an attempt to isolate complex triterpenoid saponins. We report in this paper the structure of a new complex triterpenoid saponin, brevifoliasaponin (1) with adjuvant activity against ovalbumin antigen.
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Experimental Section

Plant material
Fresh leaves of Calliandra brevifolia Benth. were obtained from the ornamental plant garden of the Federal University of Rio de Janeiro in September 2005, and a voucher specimen is maintained in the Laboratory of Chemistry of Medicinal Plants at this University.
General procedures
Melting points were determined by an Electrothermal 9200 micro-melting apparatus and are uncorrected. The optical rotations were measured on a Perkin Elmer 243B polarimeter. UV and IR spectra were measured on Shimadzu UV-1601 and Perkin Elmer 599B spectrometers, respectively. The MALDI-TOFMS was conducted using a Perseptive Voyager RP mass spectrometer. GC analyses were performed with a Shimadzu GCMS-QP5050A spectrometer using an ionization voltage of 70 eV and an ionization current of 60 µA for EI. GC was carried out with FID using a glass capillary column (0.25 × 25 m, 0.25 micron; J. & W. Scientific Incorporated, Folsom, CA, USA) DB-1. Mass spectra were taken on a VG Auto SpecQ spectrometer. NMR experiments were performed on a Brucker DRX-600 spectrometer at 300 K. NMR spectra were acquired in [D 5 ]pyridine with tetramethylsilane (δ = 0.00 ppm) used as internal standard. Silica gel columns (230 -400 mesh ASTM, Merck) and Sephadex LH-20 (Pharmacia) were used for CC. TLC was performed on silica gel plates (Kieselgel 60F 254 
The aqueous solution was passed through an Amberlite IRA-410 column. The eluate was concentrated in vacuo to give a residue (13.2 mg). A sample of the sugar residue (1 mg) was dissolved in pyridine (100 µL) and analyzed by silica gel TLC in the above described solvent system (C). After spraying with orcinol/H 2 SO 4 , rhamnose gave a green spot at R f = 0.75, xylose gave a blue spot at R f = 0.57, arabinose gave a purple spot at R f = 0.48, glucose gave a blue spot at R f = 0.40. 2-Amino-2-deoxy-glucose was analyzed by silica gel TLC in the above solvent system (D) and gave a blue spot at R f = 0.10.
Alkaline hydrolysis of compound 1
Compound 1 (100 mg) was hydrolyzed with 1 N KOH/H 2 O (5 mL) for 24 h at r. t. The reaction mixture was neutralized with 1 N HCl in water and extracted with n-BuOH. This procedure was repeated, and the resulting organic phase was evaporated in vacuo to give a residue 
Mild alkaline hydrolysis of compound 1
A solution of compound 1 (100 mg) in 5 % K 2 CO 3 /EtOH (1 : 1 v/v; 20 mL) was refluxed for 40 min. The reaction mixture was neutralized with Dowex 50W ×8, concentrated to about half the original volume and extracted with n-BuOH. The n-BuOH extract was evaporated to dryness, and the residue (77 mg) was purified by chromatography on silica gel using CHCl 3 
Reduction of compound 4
Compound 4 (4 mg) was dissolved in water (2 mL), then sodium tetrahydroborate (20 mg) was added to the resulting 
solution. The reaction mixture was allowed to stand at r. t. for 12 h, then treated with 20 % acetic acid, and concentrated to give 4a.
Molar carbohydrate composition and D,L configurations
The molar carbohydrate composition of compound 1 was determined by GC-MS analysis of its monosaccharides as their trimethylsilylated methylglycosides obtained after methanolysis (0.5 M HCl in MeOH, 24 h, 80 • C) and trimethylsilylation [9] . The configurations of the glycosides were established by capillary GC of their trimethylsilylated (-)-2-butylglycosides [10] .
Methylation analysis
Compounds 1, 3 -8 and 4a were methylated with dimethyl sulfoxide/lithium methylsulfinyl carbanion/methyl iodide [11] . The methyl ethers were obtained after hydrolysis (4 N trifluoroacetic acid, 2 h, 100 • C) and analyzed as partial alditol acetates by GC-MS [12] .
Animals
Swiss albino male mice, weighing 30 -35 g, were used. The animals were housed under standard environmental conditions and fed with standard rodent diet and water ad libitum.
Statistical analysis
The experimental data were tested for statistical differences using the Student's t test.
Hemolytic activity
Normal human red blood cell suspension (0.6 mL of 0.5 %) was mixed with 0.6 mL diluent containing 5, 10, 20, 30, 40, 50, 100, 250 and 500 µg mL −1 of compound 1, aluminum hydroxide (Al(OH) 3 ), purified Quillaja saponin (QS-21), and 5 -500 µL mL −1 of Freund's Complete Adjuvant (FCA) and Freund's Incomplete Adjuvant (FIA) in saline solution. Mixtures were incubated for 30 min at 37 • C and centrifuged at 70 × g for 10 min. Saline and distilled water were included as minimal and maximal hemolytic controls. The hemolytic percents developed by the saline control were subtracted from all groups. The adjuvant concentration inducing 50 % of the maximal hemolysis was considered the HD 50 (graphical interpolation). Experiments included triplicates at each concentration [13] .
Immunization procedure
Male Swiss mice (three months old) were subcutaneously immunized twice at weekly intervals with 100 µg ovalbumin (OVA) in 100 µL saline (SAL) as the control group or with 100 µg ovalbumin mixed with 100 µg of each adjuvant dissolved in 100 µL of saline as vehicle. Delayed type hypersensitivity (DTH) responses were assessed by measuring the increment in the right footpad thickness after subcutaneous challenge with 100 µg OVA in 100 µL saline a week after the second immunization. The footpad thickness was measured with a spring-loaded dial gauge (Mitutoyo Corp., Tokyo, Japan) before and 24, 48 and 72 h after injection. Injecting each animal with 100 µL saline in the left hind footpad served as controls. The ovalbumin specific responses were obtained by subtracting the response to OVA challenge in unimmunized control mice [14] .
Result and Discussion
Compound 1 was obtained as an amorphous solid and gave a positive Liebermann-Burchard test for a triterpenoidal saponin. It revealed a quasi-molecular ion peak at m/z = 2592.8138 [M+Na] + in the MALDI-TOFMS. In the 13 C NMR spectrum, of the 121 carbon signals observed, there are fifteen methyl groups, twenty-eight methylene groups (ten of which were oxygenated), sixty methine groups (fifty of which were oxygenated) and eighteen quaternary carbon atoms (eight of which were oxygenated). The number of hydrogens attached to each individual carbon atom was determined by the DEPT spectrum. On the basis of the above mentioned MS and 13 C NMR spectral data (Table 1), compound 1 was assumed to be a saponin with the molecular formula of C 121 H 189 NO 57 .
In addition to this, the UV spectrum of 1 featured an absorption at 220 nm of an α, β -unsaturated ester carbonyl group confirmed by an absorption at 1647 cm −1 in the IR spectrum. The IR spectrum showed absorptions at 3422 and 1707 cm −1 attributed to the hydroxyl and ester-carbonyl groups, respectively. .50, respectively. Evaluation of chemical shifts and spin-spin couplings allowed the identification of five β -xylopyranosyl units, two α-arabinopyranosyl units, two β -glucopyranosyl units, one 2-(acetylamino)-1-deoxy-β -glucopyranosyl unit, and one α-rhamnopyranosyl unit. The 13 C NMR spectrum of 1 (Table 1) showed one ester-carbonyl carbon at δ = 175.30 (C-28), one amide-carbonyl carbon at δ = 170.81 (COMe), three α, β -unsaturated estercarbonyl carbons at δ = 166.78 (C-1 ), 166,85 (C-1 ) and 167.49 (C-1 ), one pair of the olefinic carbon of the aglycone moiety at δ = 122.12 (CH, C-12) and 143.85 (C, C-13), three pairs of trisubstituted olefinic carbons at δ = 127.55 (C, C-2 ) and 142.68 (CH, C-3 ), 127.69 × 2 (C, C-2 and C-2 ) and 142.91 × 2 (CH, C-7 and C-7 ) and 114.57 × 2 (CH 2 , C-8 and C-8 ), and one sugar-linked methine carbon at δ = 88.68 (C-3). The upfield signal observed at δ = 175.30 suggests one sugar-linkage at C-28. The attachment of the sugar moiety to the aglycone moiety was established by 1 H-1 H COSY, HMBC and HMQC experiments. The HMBC and HMBC spectra displayed long range couplings between 2-amino-2-deoxy-glucose-H-1 at δ = 4.94 and aglycone-C-3 at δ = 88.68. The above facts suggest that compound 1 should be a 3,28-O-bis(desmoside) having eleven monosaccharides and three monoterpenic acids.
On acid hydrolysis, compound 1 gave a sapogenin, 2-amino-2-deoxy-glucose, rhamnose, arabinose, glucose, and xylose. The structure of the sapogenin, compound 2, was established as 3,16-dihydroxy-(3β ,16α)-olean-12-en-28-oic acid (echinocystic acid; Fig. 2 ) [15] by comparison with an authentic sample through m. p., [α] D , IR, 1 H NMR and EIMS. The molar carbohydrate composition of 1 indicated the presence of one 2-(acetylamino)-2-deoxy-glucose, one rhamnose, two arabinoses, two glucoses, and five xyloses [9] . Their absolute configurations were determined by GC of their trimethylsilylated (-)-2-butylglycosides [10] .
The sequence of the sugar chain of 1 was confirmed by methylation analysis [11] which fur- 
These results along with the 13 C NMR signals of 1 (Table 1 ) at δ = 64.18 (CH 2 , Glc C-6), 94.50 (CH, Glc C-1), 167.49 (C=O, MT C-1 ), and 175.30 (C=O, C-28) confirmed that C-1 and C-6 of the inter- special attention [17 -19] . Indeed, QS-21, a complex triterpenoid saponin isolated from Quillaja saponaria Molina [20] , has been evaluated in a large number of vaccines in Phase I and Phase II human clinical trials and was recently synthesized [21] . In order to investigate the biological properties of brevifoliasaponin (1), it was evaluated for hemolytic activity in vitro [13] and compared with adjuvants commonly used in animal and human experimental models (Fig. 3) , showing a hemolytic potential similar to the purified saponin QS-21 obtained from commercial extracts of Q. saponaria. In addition to this, the immunoadjuvant property of compound 1 was evaluated against ovalbumin antigen (Fig. 4) . Delayed type hypersensitivity (DTH) reaction was measured as an in vivo assay of cellular immune response. In this study, mice immunized with ovalbumin conjugated with saponins showed remarkable responses greater than those when the antigen was combined with commercial adjuvants. This response developed rapidly after immunization and persisted at high levels for at least three days [14] . The structural similarities between brevifoliasaponin (1) and QS-21 [22] may help to explain the potent adjuvant activity of these complex triterpenoid saponins [8] . The results obtained suggest a relevant adjuvant potential of the saponin 1 isolated from Calliandra brevifolia in experimental vaccine formulations.
